Show simple item record

Prognostic value of ER and PgR expression and the impact of multi-clonal expression for recurrence in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial.

dc.contributor.authorThorat, M
dc.contributor.authorLevey, PM
dc.contributor.authorJones, LJ
dc.contributor.authorPinder, SE
dc.contributor.authorBundred, NJ
dc.contributor.authorFentiman, IS
dc.contributor.authorCuzick, J
dc.date.accessioned2021-03-19T18:17:09Z
dc.date.available2021-02-15
dc.date.available2021-03-19T18:17:09Z
dc.date.issued2021-03-16
dc.identifier.citationThorat MA, Levey PM, Jones JL, Pinder SE, Bundred NJ, Fentiman IS, Cuzick J. Prognostic value of ER and PgR expression and the impact of multi-clonal expression for recurrence in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial. Clin Cancer Res. 2021 Mar 16:clincanres.4635.2020. doi: 10.1158/1078-0432.CCR-20-4635. Epub ahead of print. PMID: 33727261.en_US
dc.identifier.issn1078-0432
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/70778
dc.publisherAmerican Association for Cancer Researchen_US
dc.relation.ispartofClinical Cancer Research
dc.titlePrognostic value of ER and PgR expression and the impact of multi-clonal expression for recurrence in ductal carcinoma in situ: Results from the UK/ANZ DCIS trial.en_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1158/1078-0432.CCR-20-4635
pubs.notesNot knownen_US
pubs.publication-statusAccepteden_US
dcterms.dateAccepted2021-02-15
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Name:
Thorat_ER_in_DCIS_Accepted-ms_ ...
Size:
3.252Mb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record